1. Neuropharmacology Laboratory (Y.S., S.L.B., A.M.D.W., C.G., K.L.J., K.L., G.A.H.), Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
2. Human Neurotransmitters Laboratory (Y.S., M.P.S., G.W.L., N.E.), Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
3. Faculty of Medicine, Nursing and Health Sciences, Central Clinical School (Y.S.), Monash University, Melbourne, VIC, Australia.
4. Department of Cardiology, Alfred Hospital, Melbourne, VIC, Australia (Y.S.).
5. Iverson Health Innovation Research Institute and School of Health Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia (N.E., G.W.L.).
6. Department of Diabetes, Central Clinical School (A.M.D.W.), Monash University, Melbourne, VIC, Australia.
7. Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences (K.L.J), Monash University, Melbourne, VIC, Australia.
8. Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne, VIC, Australia (K.L.).
9. Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, VIC, Australia (K.M.D.).
10. Departments of Cardiology and Nephrology, Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Royal Perth Hospital (M.P.S.).
11. Department of Pharmacology (G.A.H.), Monash University, Melbourne, VIC, Australia.